Chief Executive Officer
Wed, Feb 19, 2020
Feb 19
exercised or converted securities in APLS
30,637 shares @ $2.14
Increased holdings by +3.00%
Option Exercise
Sale tied to a same-time option exercise
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology